Introduction Descemet membrane endothelial keratoplasty (DMEK) is the current gold standard surgical procedure to treat Fuchs endothelial keratoplasty. Cataract removal and intraocular lens (IOL) implantation can be safely combined with this corneal procedure. This paper presents a case series in which a toric intraocular lens (IOL) was used in combined DMEK and cataract surgery to correct corneal astigmatism. Methods Four eyes that had a toric IOL implanted in combined cataract and DMEK surgery were included. Results There was a reduction in manifest refractive cylinder and improvement in uncorrected and best-corrected vision in all cases. Discussion Surgeons may consider the use of toric IOLs in selected cases of combined DMEK and cataract surgery for Fuchs endothelial dystrophy.
A síndrome de Axenfeld-Rieger (SAR) é uma doença de origem hereditária com padrão autossômico dominante, com incidência de 1 em 200000 pacientes, caracterizada por distúrbios heterogêneos oculares e sistêmicos. As alterações oculares são geralmente bilaterais e afetam principalmente a íris, a córnea, a linha de Schwalbe e ângulo da câmara. Dentre as manifestações não oculares estão as malformações cardíacas e renais, pele periumbilical redundante, malformações auriculares e alterações hipofisárias. O objetivo do presente trabalho é relatar um caso de SAR de diagnóstico tardio associada a glaucoma, com evolução para dano visual grave, em paciente com diversas alterações oftalmológicas e sistêmicas, ressaltando a importância do reconhecimento precoce da SAR a fim de proporcionar um manejo clínico e cirúrgico adequados, com intuito de preservar a função visual dos pacientes e evitar prognóstico desfavorável. Palavras-chave: Glaucoma secundário, Disgenesia do segmento anterior, Embriotoxon posterior, atrofia iriana, microcornea, anodontia, Síndrome de Axenfeld Rieger.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.